Omalizumab in chronic spontaneous urticaria: A real-life experience of dose and intervals adjustments in Belgium.
(2018) Annals of allergy, asthma & immunology — Vol. 121, n° 5, p. 620-622 (2018)
Files
2018_de_Montjoie_Ann_Allergy_Asthma_Immunol.pdf
Restricted Access - Adobe PDF
- 196.18 KB
Details
- Authors
- Affiliations
Citations
De Montjoye, L., Herman, A., Dumoutier, L., Lambert, M., Tromme, I., & Baeck, M. (2018). Omalizumab in chronic spontaneous urticaria: A real-life experience of dose and intervals adjustments in Belgium. Annals of allergy, asthma & immunology, 121(5), 620-622. https://doi.org/10.1016/j.anai.2018.07.002 (Original work published 2018)